Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > BUSINESS
BUSINESS
- Once-Monthly Injectable Abilify Reduces Total Psychiatric Hospitalization Rates following Disease Relapse: Otsuka, Lundbeck
May 23, 2013
- Efficacy of Major Depressive Disorder Treatment Vortioxetine Shown in Three of Four PIII Studies: Takeda and Lundbeck
May 23, 2013
- AZ Oncology Division to Provide Information Based on Patients’ Lifestyle
May 22, 2013
- Apo Plus Station Eyes Sales Force of 300 for Established Products
May 22, 2013
- Domestic Sales of Ethical Drugs Rose 0.3% to 9,560.1 Billion Yen in FY2012: IMS Japan
May 22, 2013
- GSK Shares Clinical Trial Data with Researchers before Statistical Analysis
May 22, 2013
- Major Dispensing Pharmacy Chain Operators Expect Record High Sales and Profits in FY2013
May 21, 2013
- Five Major Dispensing Pharmacy Chain Operators’ Profits Down Due to NHI Price Revision
May 21, 2013
- Allegra AGs Pitched as Affordable Original Drugs with Production by Sanofi
May 21, 2013
- ALS Treatment Ozanezumab Designated as Orphan Drug: GSK
May 21, 2013
- AZ, BMKK Launch Once-Weekly GLP-1 Receptor Agonist Bydureon
May 20, 2013
- Takeda Slips to 3rd Place in 25 Major Pharmas’ Operating Profit Ranking
May 20, 2013
- Takeda’s Novel Diabetes Treatment GPR40 Shows Efficacy in Japanese Patients in PIII Trial
May 20, 2013
- New Rules on Settai Resulted in Fewer Serious Violations of Fair Competition Code in FY2012: Industry FTC
May 20, 2013
- 3 Major Generic-Only Makers Offer Mixed Views on Govt Promotion Measures
May 17, 2013
- FY2012 Sales Up 18% for Both Generic-Only Makers, Research-Driven Pharmas’ Generic Units; Govt Incentive Measures Biggest Contributor
May 17, 2013
- Toyama Chemical to License Novel Macrolide Agent from Cempra
May 17, 2013
- Yakult to File Elplat for New Indications of Pancreas and Gastric Cancer
May 17, 2013
- Astellas to File NDA for Enzalutamide in Japan in 1st Half of FY2013
May 17, 2013
- FY2012 Japan Pharma Market: Sales of Major Long-Listed Drugs Tumble 30-40%
May 16, 2013
ページ
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…